1. Djukic V, Milovanović J, Jotić AD, Vukasinovic M, Folic MM, Ivanov SY, Satueva DB. Laser transoral microsurgery in treatment of early laryngeal carcinoma. Eur Arch Otorhinolaryngol 2019; 276: 1747-1755. DOI: 10.1007/s00405-019-05453-1.
2.
Hans S, Baudouin R, Circiu MP, Couineau F, Lisan Q, Crevier-Buchman L, Lechien JR. Laryngeal cancer surgery: history and current indications of transoral laser microsurgery and transoral robotic surgery. J Clin Med 2022; 11: 5769. DOI: 10.3390/jcm11195769.
3.
Pedregal-Mallo D, Sánchez Canteli M, López F, Álvarez-Marcos C, Llorente JL, Rodrigo JP. Oncological and functional outcomes of transoral laser surgery for laryngeal carcinoma. Eur Arch Otorhinolaryngol 2018; 275: 2071-2077. DOI: 10.1007/s00405-018-5027-z.
4.
Putz L, Lovqvist L, Bachy V, Van der Vorst S, Jamart J, Dubois PE, et al. Evaluation of the impact of deep neuromuscular blockade on surgical conditions for laryngeal microsurgery with high frequency jet ventilation. A comparison with no block during intravenous general anesthesia with topical lidocaine. Am J Otolaryngol 2022; 43: 103187. DOI: 10.1016/j.amjoto.2021.103187.
5.
Ting CK, Lin SM, Yang YW, Tsai HJ, Lao HC, Chu YC, Tsai SK. Reversal of mivacurium chloride: edrophonium of spontaneous recovery in microscopic laryngeal surgery. Acta Anaesthesiol Sin 2001; 39: 157-162.
6.
Østergaard D, Viby-Mogensen J, Rasmussen SN, Gätke MR, Varin F. Pharmacokinetics and pharmacodynamics of mivacurium in patients phenotypically homozygous for the atypical plasma cholinesterase variant effect of injection of human cholinesterase. Anesthesiology 2005; 102: 1124-1132. DOI: 10.1097/00000542-200506000-00011.
7.
Frampton JE, McTavish D. Mivacurium. A review of its pharmacology and therapeutic potential in general anaesthesia. Drugs 1993; 45: 1066-1089. DOI: 10.2165/00003495-199345060-00009.
8.
Basta SJ. Clinical pharmacology of mivacurium chloride: a review salvatore. J Clin Anesth 1992; 4: 153-163. DOI: 10.1016/0952-8180(92) 90034-x.
9.
Appiah-Ankam J, Hunter JM. Pharmacology of neuromuscular blocking drugs. Continuing Education in Anaesthesia Critical Care & Pain 2004; 4: 29-30. DOI: https://doi.org/10.1093/bjaceaccp/mkh010.
10.
Lien CA. Development and potential clinical impairment of ultra-short-acting neuromuscular blocking agents. Br J Anaesth 2011; 107 Suppl 1: i60-i71. DOI: 10.1093/bja/aer341.
11.
Zhang Y, Xi C, Yue J, Zhao M, Wang G, et al. Comparison of 3 rates for the continuous infusion of mivacurium during ambulatory vitreoretinal surgery under general anesthesia: a prospective, randomized, controlled clinical trial. Drug Des Devel Ther 2022; 16: 3133-3143. DOI: 10.2147/DDDT.S370978.
12.
Molloy LS, Ledowski T. Mivacurium: a review. Curr Anesthesiol Rep 2018; 8: 125-129. DOI: 10.1007/s40140-018-0264-7.
13.
Cook DR, Freeman JA, Lai AA, Kang Y, Stiller RL, Aggarwal S, et al. Pharmacokinetics of mivacurium in normal patients and in those with hepatic or renal failure. Br J Anaesth 1992; 69: 580-585.
14.
Gätke MR, Bundgaard JR, Viby-Mogensen J. Two novel mutations in the BCHE gene in patients with prolonged duration of action of mivacurium or succinylcholine during anaesthesia. Pharmacogenet Genomics 2007; 17: 995-999. DOI: 10.1097/FPC.0b013e3282f06646.
15.
Savarese JJ, Ali HH, Basta SJ, Embree PB, Scott RP, Sunder N, et al. The clinical neuromuscular pharmacology of mivacurium chloride (BW B1090U). A short-acting nondepolarizing ester neuromuscular blocking drug. Anesthesiology 1988; 68: 723-732.
16.
Aronson JK. Mivacurium chloride. In: Meyler’s Side Effects of Drugs (Sixteenth Edition). Oxford: Elsevier; 2016, p. 1072-1073.
17.
Rubin LA, Lien CA, Savarese JJ. Mivacurium: a novel, short-acting, nondepolarizing muscle relaxant. Semin Anesth Perioper Med Pain 1995; 14: 245-256. DOI: https://doi.org/10.1016/S0277-0326(05) 80028-5.
18.
Lien CA, Belmont MR, Abalos A, Hass D, Savarese JJ. The nature of spontaneous recovery from mivacurium-induced neuromuscular block. Anesth Analg 1999; 88: 648-653. DOI: 10.1097/00000539-199903000-00033.
19.
Huang S, Li Q. Comparative analysis of the anesthesia effect of cisatracurium besylate and mivacurium chloride otolaryngology surgery. Evid Based Complement Alternat Med 2022; 2022: 6192409. DOI: 10.1155/2022/6192409.
20.
Chen Y, Wang B, Yao L, Feng Z. Maximum dose of continuous infusion of mivacurium for thyroid surgery under total intravenous anesthesia: a sequential trial of monitoring neurological function in 30 patients. Nan Fang Yi Ke Da Xue Xue Bao 2021; 41: 64-68. DOI: 10.12122/j.issn.1673-4254.2021.01.08 [Article in Chinese].
21.
Schumacher PM, Stadler KS, Wirz R, Leibundgut D, Pfister CA, Zbinden AM. Model-based control of neuromuscular block using mivacurium: design and clinical verification. Eur J Anaesthesiol 2006; 23: 691-699. DOI: 10.1017/S0265021506000524.
22.
Jeanne M, Tavernier B, Logier R, De Jonckheere J. Closed-loop administration of general anaesthesia: from sensor to medical device. Pharmaceutical Technology in Hospital Pharmacy 2017; 2: 63-70. DOI: https://doi.org/10.1515/pthp-2017-0017.
23.
Hunter JM. Reversal of residual neuromuscular block: complications associated with perioperative management of muscle relaxation. Br J Anaesth 2017; 119 (Suppl 1): i53-i62. DOI: 10.1093/bja/aex318.
24.
Thomsen JLD, Staehr-Rye AK, Mathiesen O, Hägi-Pedersen D, Gätke MR. A retrospective observational study of neuromuscular monitoring practice in 30,430 cases from six Danish hospitals. Anaesthesia 2020; 75: 1164-1172. DOI: 10.1111/anae.15083.
25.
Castellanos Peñaranda C, Casas Arroyave FD, Gómez FJ, Pinzón Corredor PA, Fernández JM, Velez Botero M, et al. Technical and clinical evaluation of a closed loop TIVA system with SEDLineTM spectral density monitoring: multicentric prospective cohort study. Perioper Med (Lond) 2020; 9: 1. DOI: 10.1186/s13741-019-0130-2.
26.
Dumont GA, Ansermino JM. Closed-loop control of anesthesia: a primer for anesthesiologists. Anesth Analg 2013; 117: 1130-1138. DOI: 10.1213/ANE.0b013e3182973687.
27.
Liu Y, Li M, Yang D, Zhang X, Wu A, Yao S, et al. Closed-loop control better than open-loop control of profofol TCI guided by BIS: a randomized, controlled, multicenter clinical trial to evaluate the CONCERT-CL closed-loop system. PLoS One 2015; 10: e0123862. DOI: 10.1371/journal.pone.0123862.
28.
Kansanaho M, Olkkola KT. Performance assessment of an adaptive model-based feedback controller: comparison between atracurium, mivacurium, rocuronium and vecuronium. Int J Clin Monit Comput 1996; 13: 217-224. DOI: 10.1023/a:1016956507342.
29.
Pasin L, Nardelli P, Pintaudi M, Greco M, Zambon M, Cabrini L, Zangrillo A. Closed-loop delivery systems versus manually controlled administration of total IV anesthesia: a meta-analysis of randomized clinical trials. Anesth Analg 2017; 124: 456-464. DOI: 10.1213/ANE. 0000000000001394.
30.
Gropper MA, Gropper MA, Eriksson LI, Fleisher LA, Wiener-Kronish JP, Cohen NH, Leslie K (eds.). Miller’s Anesthesia, 2-Volume Set. Elsevier Health Sciences; 2019.
31.
World Medical Association. World Medical Association Declaration of Helsinki: ethical principles for medical research involving human subjects. JAMA 2013; 310: 2191-2194. DOI: 10.1001/jama.2013. 281053.
32.
Vanlinthout LEH, Mesfin SH, Hens N, Vanacker BF, Robertson EN, Booij LHDJ. A systematic review and meta-regression analysis of mivacurium for tracheal intubation. Anaesthesia 2014; 69: 1377-1387. DOI: 10.1111/anae.12786.
33.
Xiang Z, Yan-Liang Q, Xiao-Yang S, Yan-Hui Z, Min C, Guo-Shen G, et al. Effects of promethazine or dexamethasone pretreatment on mivacurium-induced histamine release in children. Pediatr Anesth 2014; 24: 322-326. DOI: 10.1111/pan.12305.
34.
Mertes PM, Laxenaire MC, Alla F; Groupe d’Etudes des Réactions Anaphylactoïdes Peranesthésiques. Anaphylactic and anaphylactoid reactions occurring during anesthesia in France in 1999-2000. Anesthesiology 2003; 99: 536-545. DOI: 10.1097/00000542-200309000-00007.
35.
Peroni DG, Sansotta N, Bernardini R, Crisafulli G, Franceschini F, Caffarelli C, Boner AL. Muscle relaxants allergy. Int J Immunopathol Pharmacol 2011; 24 (3 Suppl): S35-S46. DOI: 10.1177/ 03946320110240s306.
36.
Claudius C, Garvey LH, Viby-Mogensen J. The undesirable effects of neuromuscular blocking drugs. Anaesthesia 2009; 64 Suppl 1: 10-21. DOI: 10.1111/j.1365-2044.2008.05866.x.
37.
Cook DR. Chapter 115 – Neuromuscular blocking agents. In: Pediatric Critical Care (Third Edition). Fuhrman BP, Zimmerman JJ (eds.). Philadelphia: Mosby; 2006, p. 1729-1747.
38.
Apfelbaum JL. Mivacurium chloride administration by infusion. Acta Anaesthesiol Scand Suppl 1995; 106: 55-57. DOI: 10.1111/j.1399-6576. 1995.tb04311.x.
39.
Janda M, Simanski O, Bajorat J, Pohl B, Noeldge-Schomburg GFE, Hofmockel R. Clinical evaluation of a simultaneous closed-loop anaesthesia control system for depth of anaesthesia and neuromuscular blockade. Anaesthesia 2011; 66: 1112-1120. DOI: 10.1111/j.1365-2044. 2011.06875.x.
40.
Kansanaho M, Olkkola KT. The effect of halothane on mivacurium infusion requirements in adult surgical patients. Acta Anaesthesiol Scand 1997; 41: 754-759. DOI: 10.1111/j.1399-6576.1997.tb04779.x.
41.
Chen Y, Huang L, Li Y, Tong L, Wang X, Hu K, Feng Z. Sequential method for determining the maximum dose of mivacurium continuously infused for intraoperative neuromonitoring in thyroid surgery. Nan Fang Yi Ke Da Xue Xue Bao 2018; 38: 1472-1475. doi: 10.12122/ j.issn.1673-4254.2018.12.12.
42.
Heier T, Caldwell JE, Feiner JR, Liu L, Ward T, Wright PMC. Relationship between normalized adductor pollicis train-of-four ratio and manifestations of residual neuromuscular block. Anesthesiology 2010; 113: 825-832. DOI: 10.1097/ALN.Ob013e3181ebddca.
43.
Heier T, Feiner JR, Wright PMC, Ward T, Caldwell JE. Sex-related differences in the relationship between acceleromyographic adductor pollicis train-of-four ratio and clinical manifestations of residual neuromuscular block: a study in healthy volunteers during near steady-state infusion of mivacurium. Br J Anaesth 2012; 108: 444-451. DOI: 10.1093/bja/aer419.
44.
Saito Y, Iemitsu M, Otsuki T, Maeda S, Ajisaka R. Gender differences in brachial blood flow during fatiguing intermittent handgrip. Med Sci Sports Exerc 2008; 40: 684-690. DOI: 10.1249/MSS. 0b013e3181614327.
45.
Blitt CD, Petty WC, Alberternst EE, Wright BJ. Correlation of plasma cholinesterase activity and duration of action of succinylcholine during pregnancy. Anesth Analg 1977; 56: 78-83. DOI: 10.1213/00000539-197701000-00019.
46.
Leighton BL, Cheek TG, Gross JB, Apfelbaum JL, Shantz BB, Guts- che BB, Rosenberg H. Succinylcholine pharmacodynamics in peripartum patients. Anesthesiology 1986; 64: 202-205. DOI: 10.1097/00000542-198602000-00012.
47.
Inangil G, Deniz S, Gulcan Kurt Y, Keskin U, Bakal O, Sen H, et al. How important is the butyrylcholinesterase level for cesarean section. Pregnancy Hypertens 2016; 6: 26-29. DOI: 10.1016/j.preghy.2016. 01.004.
48.
Andersson ML, Møller AM, Wildgaard K. Butyrylcholinesterase deficiency and its clinical importance in anaesthesia: a systematic review. Anaesthesia 2019; 74: 518-528. DOI: 10.1111/anae.14545.
49.
Lien CA, Schmith VD, Embree PB, Belmont MR, Wargin WA, Savarese JJ. The pharmacokinetics and pharmacodynamics of the stereoisomers of mivacurium in patients receiving nitrous oxide/opioid/barbiturate anesthesia. Anesthesiology 1994; 80: 1296-1302. DOI: 10.1097/00000542-199406000-00017.
50.
Shanks CA, Fragen RJ, Pemberton D, Katz JA, Risner ME. Mivacurium-induced neuromuscular blockade following single bolus doses and with continuous infusion during either balanced or enflurane anesthesia. Anesthesiology 1989; 71: 362-366. DOI: 10.1097/ 00000542-198909000-00008.
This is an Open Access journal, all articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International (CC BY-NC-SA 4.0). License (http://creativecommons.org/licenses/by-nc-sa/4.0/), allowing third parties to copy and redistribute the material in any medium or format and to remix, transform, and build upon the material, provided the original work is properly cited and states its license.
